# Velcade for Proliferative Lupus Nephritis

> **NCT01169857** · PHASE4 · WITHDRAWN · sponsor: **The Rogosin Institute**

## Conditions studied

- Lupus Nephritis
- Proteinuria
- Hematuria

## Interventions

- **DRUG:** Velcade

## Key facts

- **NCT ID:** NCT01169857
- **Lead sponsor:** The Rogosin Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-08
- **Primary completion:** 2012-08
- **Final completion:** 2012-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No participants were enrolled.
- **Last updated:** 2012-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01169857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01169857, "Velcade for Proliferative Lupus Nephritis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01169857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*